Laboratory of Biochemistry and Environmental Toxicology, Department of Biochemistry, Faculty of Sciences, University of Badji Mokhtar, BP 12, Sidi Amar, Annaba, Algeria.
Laboratory of Biology, Environment and Health, Department of Cellular and Molecular Biology, Faculty of Natural Science and Life, El Oued University, El Oued, Algeria.
Chem Biodivers. 2024 Apr;21(4):e202302005. doi: 10.1002/cbdv.202302005. Epub 2024 Mar 7.
This study aimed to identify the phytochemical compounds of Matricaria pubescens by LC-MS/MS and evaluate the potential protective effect of its supplementation in high-fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) in adult rats through modulation of oxidative stress and histopathological changes. Twenty-four male rats were randomly divided into four groups. The first group served as control and received the standard diet. The second group (HFD) received a high-fat diet only (30 % of sheep fat). The third group's (control+MP) animals received a standard diet supplemented with 5 % M. pubescens (w/w). The fourth group (HFD+MP) received a high-fat diet supplemented with 5 % M. pubescens for 16 weeks. LC-MS/MS analysis showed that M. pubescens contains many phytochemical compounds. It was observed that the ethanolic extract of M. pubescens has a higher phenolic content than the aqueous extract. The supplementation of M. pubescens (5 % w/w) to HFD rats decreased significantly (p<0.01) body weight, liver and epididymal adipose tissue relative weights, glycemia, triglycerides (TG), insulin resistance, liver markers, TNF-α, malondialdehyde (MDA), protein carbonyl (PCO), advanced oxidation protein products (AOPP) level, and increased reduced glutathione (GSH) level, glutathione peroxidase (GPx), glutathione-S-transferase (GST), superoxide dismutase (SOD), and catalase activities as well as ameliorated histological alterations through the reduction hepatic lipid deposition and adipocytes hypertrophy compared to the HFD group. We conclude that M. pubescens powder may be effective for correcting hyperglycemia, hypertriglyceridemia, insulin resistance, and liver markers while decreasing inflammation and oxidative stress in the liver of high-fat diet-fed rats.
本研究旨在通过调节氧化应激和组织病理学变化,鉴定欧洲春黄菊中的植物化学化合物,并评估其在高脂饮食(HFD)诱导的成年大鼠非酒精性脂肪性肝病(NAFLD)中的潜在保护作用。将 24 只雄性大鼠随机分为四组。第一组作为对照组,给予标准饮食。第二组(HFD)仅给予高脂肪饮食(30%绵羊脂肪)。第三组(对照+MP)动物给予 5%欧洲春黄菊(w/w)补充的标准饮食。第四组(HFD+MP)给予补充 5%欧洲春黄菊的高脂肪饮食 16 周。LC-MS/MS 分析表明,欧洲春黄菊含有许多植物化学化合物。结果表明,欧洲春黄菊的乙醇提取物比水提取物具有更高的酚含量。将欧洲春黄菊(5%w/w)补充到 HFD 大鼠中,可显著降低(p<0.01)体重、肝脏和附睾脂肪组织相对重量、血糖、甘油三酯(TG)、胰岛素抵抗、肝标志物、TNF-α、丙二醛(MDA)、蛋白质羰基(PCO)、高级氧化蛋白产物(AOPP)水平,增加还原型谷胱甘肽(GSH)水平、谷胱甘肽过氧化物酶(GPx)、谷胱甘肽-S-转移酶(GST)、超氧化物歧化酶(SOD)和过氧化氢酶活性,并通过减少肝脂质沉积和脂肪细胞肥大来改善组织学改变与 HFD 组相比。我们得出结论,欧洲春黄菊粉末可能有效纠正高血糖、高三酰甘油血症、胰岛素抵抗和肝标志物,同时降低高脂肪饮食喂养大鼠肝脏的炎症和氧化应激。
Horm Mol Biol Clin Investig. 2020-2-14
BMC Complement Med Ther. 2022-11-24
J Complement Integr Med. 2016-6-1
Antioxidants (Basel). 2024-11-28